Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Home
/
Brands
/
Novartis Pharmaceuticals Corp.

Novartis Pharmaceuticals Corp. Recalls

All product recalls associated with Novartis Pharmaceuticals Corp..

Get alerts for this brand

Recall Summary

Total Recalls

597

Past Year

4

Class I (Serious)

18

Most Recent

May 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 521–540 of 597 recalls

Lescol XL (Novartis) – chemical contamination (2013)

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Class IIModerate

FDAAug 8, 2013Nationwide• Novartis Pharmaceuticals Corp.

Diovan (Novartis) – chemical contamination (2013)

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Class IIModerate

FDAAug 8, 2013Nationwide• Novartis Pharmaceuticals Corp.

Exforge (Novartis) – Chemical Contamination (2013)

1...25 262728 29 30

Page 27 of 30Next

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Class IIModerate

FDAAug 8, 2013Nationwide• Novartis Pharmaceuticals Corp.

Diovan (Novartis) – Chemical Contamination (2013)

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Class IIModerate

FDAAug 8, 2013Nationwide• Novartis Pharmaceuticals Corp.

Tekturna (Novartis) – chemical contamination (2013)

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Class IIModerate

FDAAug 8, 2013Nationwide• Novartis Pharmaceuticals Corp.

Exforge (Novartis) – chemical contamination (2013)

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Class IIModerate

FDAAug 8, 2013Nationwide• Novartis Pharmaceuticals Corp.

Exforge HCT (Novartis) – chemical contamination (2013)

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Class IIModerate

FDAAug 8, 2013Nationwide• Novartis Pharmaceuticals Corp.

Belladonna Alkaloids Tablets (West-Ward) – Foreign Substance (2013)

Presence of Foreign Substance: black specks comprised of degraded organic material found on tablets

Class IIModerate

FDAJul 30, 2013Nationwide• West-Ward Pharmaceutical Corp.

Lisinopril Tablets (West-Ward) – Impurity Specification (2013)

Failed Impurities/Degradation Specifications: Out of Specification results for Individual Other Unknown Related Compounds were obtained at the 48 month time-point.

Class IIModerate

FDAJul 30, 2013Nationwide• West-Ward Pharmaceutical Corp.

Soleil Fan Heater (Home Depot) – Fire hazard (2013)

This recall involves Soleil portable fan heaters with model number LH-707. The model number is printed on the underside of the fan on a sticker. The circular table fans are white plastic and are 1500 watts. Soleil is printed on the center front of the fan. The fans have a thermostat control on the bottom left front and a power and fan speed control on the bottom right front. The fans measure about 8 inches in diameter by 8½ inches tall.

CPSCJul 25, 2013Nationwide• Shanghai Limach Mfg. Co. Ltd., of China

Clobetasol Propionate Cream (Hi-Tech Pharmacal) – Label Mix-up (2013)

Labeling: Label Mix-up; some cartons labeled as Clobetasol Propionate Cream USP contain tubes labeled as Clobetasol Propionate Gel USP. The actual product in the tube is Clobetasol Propionate Cream USP

FDAJul 25, 2013Nationwide• Hi-Tech Pharmacal Co., Inc.

Ethambutol Tablets (West-Ward) – Surface Defect (2013)

Discoloration: Ethambutol HCl Tablets 400 mg is being recalled due to a Out of Specification result for description testing for a surface defect of ink.

Class IIModerate

FDAJun 4, 2013GA• West-Ward Pharmaceutical Corp.

Belladonna Alkaloids Tablets (West-Ward) – foreign substance (2013)

Presence of Foreign Substance: Belladonna Alkaloids with Phenobarbital Tablets with black specks comprised of degraded organic material on tablets.

Class IIModerate

FDAMay 16, 2013Nationwide• West-Ward Pharmaceutical Corp.

Belladonna Alkaloids Tablets (West-Ward) – cross contamination (2013)

Cross contamination with other products: Belladonna Alkaloids with Phenobarbital Tablets contained a trace amount of Methocarbamol.

Class IIModerate

FDAMay 16, 2013Nationwide• West-Ward Pharmaceutical Corp.

Nicardipine Hydrochloride Injection (West-ward) – Impurity Specification (2013)

Failed Impurity/Degradation Specifications; out of specification value for impurity Nitrophenylpuridine Derivative (NPP-D)

FDAMay 13, 2013Nationwide• West-ward Pharmaceutical Corp.

CLENZIderm (Medicis) – mislabeled product (2013)

cGMP Deviations; during the production process, CLENZIderm M.D. Daily Foam Cleanser was filled into some bottles labeled as CLENZIderm M.D. Pore Therapy

Class IIModerate

FDAMay 1, 2013Nationwide• Medicis Pharmaceutical Corp

HydrOXYzine (Hi-Tech Pharmacal) – subpotent medication (2013)

Subpotent; 24 month stability test station

FDAApr 30, 2013Nationwide• Hi-Tech Pharmacal Co., Inc.

Comprehensive Injection #4 (Axium Healthcare) – Sterility Concerns (2013)

Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.

Class IIModerate

FDAApr 17, 2013CO, GA, MI +1 more• Axium Healthcare Pharmacy dba Balanced Solutions Compounding

Betamethasone Injectable (Axium Healthcare) – sterility concern (2013)

Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.

Class IIModerate

FDAApr 17, 2013CO, GA, MI +1 more• Axium Healthcare Pharmacy dba Balanced Solutions Compounding

Triamcinolone Acetonide Injectable (Axium Healthcare) – sterility concern (2013)

Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.

Class IIModerate

FDAApr 17, 2013CO, GA, MI +1 more• Axium Healthcare Pharmacy dba Balanced Solutions Compounding